Option chain shows key data for HeartSciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for HeartSciences.

HeartSciences (NASDAQ:HSCS) Stock, Option Chain

HeartSciences

Heart Test Laboratories

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

BIVI

FLYX

FRES

FRZA

FUTU

GBNY

HSCS

JFBR

MLGO

Merrill Lynch & Strategic Return Notes for Select 10 Index

NUKK

ORGS

SFIX

SNOW

UXIN

XPON

Why Maison Solutions Shares Are Trading Higher By Around 91%; Here Are 20 Stocks Moving Premarket

xr:d:DAFuNkYNhBk:2,j:4920585249529610575,t:23091206

Intraday Update

AKAN

AMPG

ASTS

AUTL

BNRG

BRSH

BSFC

BTOG

BURU

CBRL

CRKN

DESP

DOCS

EDBL

FFIE

GLOB

GWAV

HOOD

JDZG

KXIN

LIDR

LSDI

NEGG

NVAX

ONCO

OUST

PEGY

RCRT

RDDT

SCPX

SLNA

SPWR

Why Cracker Barrel Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Image32

Earnings

Eurozone

Commodities

AMAT

US Stocks Edge Higher; Applied Materials Posts Upbeat Earnings

HeartSciences Inc

Press Releases

HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

HeartSciences Selected to Demonstrate MyoVista® wavECG™ at the United Nations General Assembly Digital Health Symposium as a Technology to Radically Transform Healthcare

General

Innovation Value Institute Analysis Demonstrates HeartSciences' MyoVista® wavECG™ Potential to Improve Cardiovascular Pathway Efficiency

HeartSciences Provides Business Update and Reports Fiscal 2024 Financial Results

Financing

HeartSciences Closes Non-Dilutive Financing to Increase its Cash Runaway Ahead of Upcoming FDA Submission

HeartSciences Provides Business Update and Reports First Quarter Fiscal 2025 Financial Results

"Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential"

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

HeartSciences' AI-ECG Algorithms Assigned CMS Medicare and Medicaid Reimbursement

HeartSciences Provides Business Update and Reports Second Quarter Fiscal 2025 Financial Results

Comments

HeartSciences

HeartSciences (HSCS) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga